 | • レポートコード：MRC23Q36275 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の血漿レーギン迅速（RPR）検査市場について調査・分析し、世界の血漿レーギン迅速（RPR）検査市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（モノクローナル抗体検査、免疫蛍光検査、蛍光トレポネーマ抗体吸収検査、T.淡蒼球赤血球凝集アッセイ）、用途別セグメント分析（病院、専門クリニック、診断検査室、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Cardinal Health、Abbott、BD、Roche Holding、Thermo Fisher Scientific、、Siemens、SEKISUI Diagnostics、Immunostics、Novacyt、Arlington Scientific、Lorne Laboratories、Meridian Bioscience、Bio-Rad Laboratories、Mediclone Biotech、Newmarket Biomedicalなどが含まれています。世界の血漿レーギン迅速（RPR）検査市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、血漿レーギン迅速（RPR）検査市場規模を推定する際に考慮しました。本レポートは、血漿レーギン迅速（RPR）検査の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、血漿レーギン迅速（RPR）検査に関するビジネス上の意思決定に役立てることを目的としています。 ・血漿レーギン迅速（RPR）検査市場の概要 - 血漿レーギン迅速（RPR）検査のタイプ別セグメント - 世界の血漿レーギン迅速（RPR）検査市場規模：タイプ別分析（モノクローナル抗体検査、免疫蛍光検査、蛍光トレポネーマ抗体吸収検査、T.淡蒼球赤血球凝集アッセイ） - 血漿レーギン迅速（RPR）検査の用途別セグメント - 世界の血漿レーギン迅速（RPR）検査市場規模：用途別分析（病院、専門クリニック、診断検査室、その他） - 世界の血漿レーギン迅速（RPR）検査市場規模予測（2018年-2029年） ・血漿レーギン迅速（RPR）検査市場の成長トレンド - 血漿レーギン迅速（RPR）検査の地域別市場規模（2018年-2029年） - 血漿レーギン迅速（RPR）検査市場ダイナミクス - 血漿レーギン迅速（RPR）検査の業界動向 - 血漿レーギン迅速（RPR）検査市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：モノクローナル抗体検査、免疫蛍光検査、蛍光トレポネーマ抗体吸収検査、T.淡蒼球赤血球凝集アッセイ - 世界の血漿レーギン迅速（RPR）検査のタイプ別市場規模（2018年-2023年） - 世界の血漿レーギン迅速（RPR）検査のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、専門クリニック、診断検査室、その他 - 世界の血漿レーギン迅速（RPR）検査の用途別市場規模（2018年-2023年） - 世界の血漿レーギン迅速（RPR）検査の用途別市場規模（2024年-2029年） ・血漿レーギン迅速（RPR）検査の地域別市場規模 - 北米の血漿レーギン迅速（RPR）検査市場規模（2018年-2029年） - アメリカの血漿レーギン迅速（RPR）検査市場規模（2018年-2029年） - ヨーロッパの血漿レーギン迅速（RPR）検査市場規模（2018年-2029年） - アジア太平洋の血漿レーギン迅速（RPR）検査市場規模（2018年-2029年） - 中国の血漿レーギン迅速（RPR）検査市場規模（2018年-2029年） - 日本の血漿レーギン迅速（RPR）検査市場規模（2018年-2029年） - 韓国の血漿レーギン迅速（RPR）検査市場規模（2018年-2029年） - インドの血漿レーギン迅速（RPR）検査市場規模（2018年-2029年） - オーストラリアの血漿レーギン迅速（RPR）検査市場規模（2018年-2029年） - 中南米の血漿レーギン迅速（RPR）検査市場規模（2018年-2029年） - 中東・アフリカの血漿レーギン迅速（RPR）検査市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Cardinal Health、Abbott、BD、Roche Holding、Thermo Fisher Scientific、、Siemens、SEKISUI Diagnostics、Immunostics、Novacyt、Arlington Scientific、Lorne Laboratories、Meridian Bioscience、Bio-Rad Laboratories、Mediclone Biotech、Newmarket Biomedical ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Plasma Reagin Rapid (RPR) Test market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Plasma Reagin Rapid (RPR) Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Plasma Reagin Rapid (RPR) Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Plasma Reagin Rapid (RPR) Test in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Plasma Reagin Rapid (RPR) Test include Cardinal Health, Abbott, BD, Roche Holding, Thermo Fisher Scientific
, Siemens, SEKISUI Diagnostics, Immunostics and Novacyt, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasma Reagin Rapid (RPR) Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Reagin Rapid (RPR) Test.
The Plasma Reagin Rapid (RPR) Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Plasma Reagin Rapid (RPR) Test market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma Reagin Rapid (RPR) Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Cardinal Health
Abbott
BD
Roche Holding
Thermo Fisher Scientific
Siemens
SEKISUI Diagnostics
Immunostics
Novacyt
Arlington Scientific
Lorne Laboratories
Meridian Bioscience
Bio-Rad Laboratories
Mediclone Biotech
Newmarket Biomedical
Segment by Type
Monoclonal Antibodies Test
Immunofluorescence Test
Fluorescent Treponemal Antibody Absorption Test
T. Pallidum Hemagglutination Assay
Segment by Application
Hospitals
Specialty Clinics
Diagnostics Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasma Reagin Rapid (RPR) Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Reagin Rapid (RPR) Test Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies Test
1.2.3 Immunofluorescence Test
1.2.4 Fluorescent Treponemal Antibody Absorption Test
1.2.5 T. Pallidum Hemagglutination Assay
1.3 Market by Application
1.3.1 Global Plasma Reagin Rapid (RPR) Test Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostics Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasma Reagin Rapid (RPR) Test Market Perspective (2018-2029)
2.2 Plasma Reagin Rapid (RPR) Test Growth Trends by Region
2.2.1 Global Plasma Reagin Rapid (RPR) Test Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Plasma Reagin Rapid (RPR) Test Historic Market Size by Region (2018-2023)
2.2.3 Plasma Reagin Rapid (RPR) Test Forecasted Market Size by Region (2024-2029)
2.3 Plasma Reagin Rapid (RPR) Test Market Dynamics
2.3.1 Plasma Reagin Rapid (RPR) Test Industry Trends
2.3.2 Plasma Reagin Rapid (RPR) Test Market Drivers
2.3.3 Plasma Reagin Rapid (RPR) Test Market Challenges
2.3.4 Plasma Reagin Rapid (RPR) Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma Reagin Rapid (RPR) Test Players by Revenue
3.1.1 Global Top Plasma Reagin Rapid (RPR) Test Players by Revenue (2018-2023)
3.1.2 Global Plasma Reagin Rapid (RPR) Test Revenue Market Share by Players (2018-2023)
3.2 Global Plasma Reagin Rapid (RPR) Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasma Reagin Rapid (RPR) Test Revenue
3.4 Global Plasma Reagin Rapid (RPR) Test Market Concentration Ratio
3.4.1 Global Plasma Reagin Rapid (RPR) Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Reagin Rapid (RPR) Test Revenue in 2022
3.5 Plasma Reagin Rapid (RPR) Test Key Players Head office and Area Served
3.6 Key Players Plasma Reagin Rapid (RPR) Test Product Solution and Service
3.7 Date of Enter into Plasma Reagin Rapid (RPR) Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma Reagin Rapid (RPR) Test Breakdown Data by Type
4.1 Global Plasma Reagin Rapid (RPR) Test Historic Market Size by Type (2018-2023)
4.2 Global Plasma Reagin Rapid (RPR) Test Forecasted Market Size by Type (2024-2029)
5 Plasma Reagin Rapid (RPR) Test Breakdown Data by Application
5.1 Global Plasma Reagin Rapid (RPR) Test Historic Market Size by Application (2018-2023)
5.2 Global Plasma Reagin Rapid (RPR) Test Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Plasma Reagin Rapid (RPR) Test Market Size (2018-2029)
6.2 North America Plasma Reagin Rapid (RPR) Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Plasma Reagin Rapid (RPR) Test Market Size by Country (2018-2023)
6.4 North America Plasma Reagin Rapid (RPR) Test Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasma Reagin Rapid (RPR) Test Market Size (2018-2029)
7.2 Europe Plasma Reagin Rapid (RPR) Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Plasma Reagin Rapid (RPR) Test Market Size by Country (2018-2023)
7.4 Europe Plasma Reagin Rapid (RPR) Test Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasma Reagin Rapid (RPR) Test Market Size (2018-2029)
8.2 Asia-Pacific Plasma Reagin Rapid (RPR) Test Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Plasma Reagin Rapid (RPR) Test Market Size by Region (2018-2023)
8.4 Asia-Pacific Plasma Reagin Rapid (RPR) Test Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasma Reagin Rapid (RPR) Test Market Size (2018-2029)
9.2 Latin America Plasma Reagin Rapid (RPR) Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Plasma Reagin Rapid (RPR) Test Market Size by Country (2018-2023)
9.4 Latin America Plasma Reagin Rapid (RPR) Test Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma Reagin Rapid (RPR) Test Market Size (2018-2029)
10.2 Middle East & Africa Plasma Reagin Rapid (RPR) Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Plasma Reagin Rapid (RPR) Test Market Size by Country (2018-2023)
10.4 Middle East & Africa Plasma Reagin Rapid (RPR) Test Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Detail
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Plasma Reagin Rapid (RPR) Test Introduction
11.1.4 Cardinal Health Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.1.5 Cardinal Health Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Plasma Reagin Rapid (RPR) Test Introduction
11.2.4 Abbott Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 BD
11.3.1 BD Company Detail
11.3.2 BD Business Overview
11.3.3 BD Plasma Reagin Rapid (RPR) Test Introduction
11.3.4 BD Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.3.5 BD Recent Development
11.4 Roche Holding
11.4.1 Roche Holding Company Detail
11.4.2 Roche Holding Business Overview
11.4.3 Roche Holding Plasma Reagin Rapid (RPR) Test Introduction
11.4.4 Roche Holding Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.4.5 Roche Holding Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific
Company Detail
11.5.2 Thermo Fisher Scientific
Business Overview
11.5.3 Thermo Fisher Scientific
Plasma Reagin Rapid (RPR) Test Introduction
11.5.4 Thermo Fisher Scientific
Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.5.5 Thermo Fisher Scientific
Recent Development
11.6 Siemens
11.6.1 Siemens Company Detail
11.6.2 Siemens Business Overview
11.6.3 Siemens Plasma Reagin Rapid (RPR) Test Introduction
11.6.4 Siemens Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.6.5 Siemens Recent Development
11.7 SEKISUI Diagnostics
11.7.1 SEKISUI Diagnostics Company Detail
11.7.2 SEKISUI Diagnostics Business Overview
11.7.3 SEKISUI Diagnostics Plasma Reagin Rapid (RPR) Test Introduction
11.7.4 SEKISUI Diagnostics Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.7.5 SEKISUI Diagnostics Recent Development
11.8 Immunostics
11.8.1 Immunostics Company Detail
11.8.2 Immunostics Business Overview
11.8.3 Immunostics Plasma Reagin Rapid (RPR) Test Introduction
11.8.4 Immunostics Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.8.5 Immunostics Recent Development
11.9 Novacyt
11.9.1 Novacyt Company Detail
11.9.2 Novacyt Business Overview
11.9.3 Novacyt Plasma Reagin Rapid (RPR) Test Introduction
11.9.4 Novacyt Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.9.5 Novacyt Recent Development
11.10 Arlington Scientific
11.10.1 Arlington Scientific Company Detail
11.10.2 Arlington Scientific Business Overview
11.10.3 Arlington Scientific Plasma Reagin Rapid (RPR) Test Introduction
11.10.4 Arlington Scientific Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.10.5 Arlington Scientific Recent Development
11.11 Lorne Laboratories
11.11.1 Lorne Laboratories Company Detail
11.11.2 Lorne Laboratories Business Overview
11.11.3 Lorne Laboratories Plasma Reagin Rapid (RPR) Test Introduction
11.11.4 Lorne Laboratories Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.11.5 Lorne Laboratories Recent Development
11.12 Meridian Bioscience
11.12.1 Meridian Bioscience Company Detail
11.12.2 Meridian Bioscience Business Overview
11.12.3 Meridian Bioscience Plasma Reagin Rapid (RPR) Test Introduction
11.12.4 Meridian Bioscience Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.12.5 Meridian Bioscience Recent Development
11.13 Bio-Rad Laboratories
11.13.1 Bio-Rad Laboratories Company Detail
11.13.2 Bio-Rad Laboratories Business Overview
11.13.3 Bio-Rad Laboratories Plasma Reagin Rapid (RPR) Test Introduction
11.13.4 Bio-Rad Laboratories Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.13.5 Bio-Rad Laboratories Recent Development
11.14 Mediclone Biotech
11.14.1 Mediclone Biotech Company Detail
11.14.2 Mediclone Biotech Business Overview
11.14.3 Mediclone Biotech Plasma Reagin Rapid (RPR) Test Introduction
11.14.4 Mediclone Biotech Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.14.5 Mediclone Biotech Recent Development
11.15 Newmarket Biomedical
11.15.1 Newmarket Biomedical Company Detail
11.15.2 Newmarket Biomedical Business Overview
11.15.3 Newmarket Biomedical Plasma Reagin Rapid (RPR) Test Introduction
11.15.4 Newmarket Biomedical Revenue in Plasma Reagin Rapid (RPR) Test Business (2018-2023)
11.15.5 Newmarket Biomedical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details